Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Eda

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Neuroimage|November 8, 2001
Cortical mapping of gait in humans: a near-infrared spectroscopic topography studyI Miyai, H C Tanabe, I Sase, et al.
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Leukemia|February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activityH Eda, L Santo, D D Cirstea, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Neuroimage|November 8, 2001
Cortical mapping of gait in humans: a near-infrared spectroscopic topography studyI Miyai, H C Tanabe, I Sase, et al.
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Leukemia|February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activityH Eda, L Santo, D D Cirstea, et al.
Pageof 4